Regulation of Inflammation by Bidirectional Signaling through CD137 and Its Ligand
2
조회
0
다운로드
1
인용
0
참고문헌
키워드
초록
Although the majority of research on CD137 has been directed to T cells, it is becoming clear that this molecule has distinct functions in other lineages of cells, including nonhematopoietic cells. In particular, emerging evidence suggests that the CD137-its ligand (CD137L) network involving immune cells and non-immune cells, directly or indirectly regulates inflammation in both positive and negative manners. Bidirectional signaling through both CD137 and CD137L is critical in the evolution of inflammation: 1) CD137L signaling plays an indispensible role in the activation and recruitment of neutrophils by inducing the production of proinflammatory cytokines and chemokines in hematopoietic and non-hematopoietic cells such as macrophages, endothelial cells and epithelial cells; 2) CD137 signaling in NK cells and T cells is required for their activation and can influence other cells participating in inflammation via either their production of proinflammatory cytokines or engagement of CD137L by their cell surface CD137: 3) CD137 signaling can suppress inflammation by controlling regulatory activities of dendritic cells and regulatory T cells. As recognition grows of the role of dysregulated CD137 or CD137L stimulation in inflammatory diseases, significant efforts will be needed to develop antagonists to CD137 or CD137L.
Abstract
Although the majority of research on CD137 has been directed to T cells, it is becoming clear that this molecule has distinct functions in other lineages of cells, including nonhematopoietic cells. In particular, emerging evidence suggests that the CD137-its ligand (CD137L) network involving immune cells and non-immune cells, directly or indirectly regulates inflammation in both positive and negative manners. Bidirectional signaling through both CD137 and CD137L is critical in the evolution of inflammation: 1) CD137L signaling plays an indispensible role in the activation and recruitment of neutrophils by inducing the production of proinflammatory cytokines and chemokines in hematopoietic and non-hematopoietic cells such as macrophages, endothelial cells and epithelial cells; 2) CD137 signaling in NK cells and T cells is required for their activation and can influence other cells participating in inflammation via either their production of proinflammatory cytokines or engagement of CD137L by their cell surface CD137: 3) CD137 signaling can suppress inflammation by controlling regulatory activities of dendritic cells and regulatory T cells. As recognition grows of the role of dysregulated CD137 or CD137L stimulation in inflammatory diseases, significant efforts will be needed to develop antagonists to CD137 or CD137L.
참고문헌 (34)
- Medzhitov, R., "Origin and physiological roles of inflammation", Nature, 454, pp.428~435 (2008)
- Barton, G. M, "A calculated response: control of inflammation by the innate immune system", J. Clin. Invest, 118, pp.413~420 (2008)
- Seo, S. K., "4-1BB-mediated immunotherapy of rheumatoid arthritis", Nat. Med, 10, pp.1088~1094 (2004)
- Olofsson, P. S., "CD137 is expressed in human atherosclerosis and promotes development of plaque inflammation in hypercholesterolemic mice", Circulation, 117, pp.1292~1301 (2008)
- Jeon, H. J., "CD137 (4-1BB) Deficiency Reduces Atherosclerosis in Hyperlipidemic Mice", CIRCULATION, 121(9), pp.1124~126, LIPPINCOTT WILLIAMS WILKINS
- Dumitriu, I. E., "High levels of costimulatory receptors OX40 and 4-1BB characterize CD4+CD28null T cells in patients with acute coronary syndrome", Circ. Res, 110, pp.857~869 (2012)
- Haga, T., "Attenuation of experimental autoimmune myocarditis by blocking T cell activation through 4-1BB pathway", J. Mol. Cell. Cardiol, 46, pp.719~727 (2009)
- Seo, S. K, "Blocking 4-1BB", 4-1BB ligand interactions prevents herpetic stromal keratitis, 2003, pp.171, 576~583
- Wang, J., "Role of 4-1BB in allograft rejection mediated by CD8+ T cells", Am. J. Transplant, 3, pp.543~551 (2003)
- Cho, H. R., "Blockade of 4-1BB (CD137)", 4-1BB ligand interactions increases allograft survival, 2004, pp.17, 351~361
- Cheung, C. T, "Neutralizing anti-4-1BBL treatment improves cardiac function in viral myocarditis", Lab. Invest, 87, pp.651~661 (2007)
- Kim, W., "Induction of lethal graft-versus-host disease by anti-CD137 monoclonal antibody in mice prone to chronic graft-versus-host disease", Biol. Blood Marrow Transplant, 15, pp.306~314 (2009)
- Blazar, B. R., "Ligation of 4-1BB (CDw137) regulates graft-versus-host disease, graft-versus- leukemia, and graft rejection in allogeneic bone marrow transplant recipients", J. Immunol, 166, pp.3174~3183 (2001)
- Croft, M., "The role of TNF superfamily members in T-cell function and diseases", Nat. Rev. Immunol, 9, pp.271~285 (2009)
- 김윤근, "4-1BB engagement costimulates NKT cell activation and exacerbates NKT cell ligand-induced airway hyperresponsiveness and inflammation", JOURNAL OF IMMUNOLOGY, 180(4), pp.2062~2068, AMER ASSOC IMMUNOLOGISTS
- Vinay, D. S., "CD137-deficient mice have reduced NK", NKT cell numbers and function, are resistant to lipopolysaccharide-induced shock syndromes, and have lower IL-4 responses, 2004, pp.173, 4218~4229
- 이상철, "4-1BB (CD137) is required for rapid clearance of Listeria monocytogenes infection", INFECTION AND IMMUNITY, 73(8), pp.5144~5151, AMER SOC MICROBIOLOGY
- Heinisch, I. V., "CD137 activation abrogates granulocyte-macrophage colony- stimulating factor-mediated anti-apoptosis in neutrophils", Eur. J. Immunol, 30, pp.3441~3446 (2000)
- Nishimoto, H., "Costimulation of mast cells by 4-1BB, a member of the tumor necrosis factor receptor superfamily, with the high-affinity IgE receptor", Blood, 106, pp.4241~4248 (2005)
- Heinisch, I. V, "Functional CD137 receptors are expressed by eosinophils from patients with IgE-mediated allergic responses but not by eosinophils from patients with non-IgE-mediated eosinophilic disorders", J. Allergy Clin. Immunol, 108, pp.21~28 (2001)
- Futagawa, T, "Expression and function of 4-1BB and 4-1BB ligand on murine dendritic cells", Int. Immunol, 14, pp.275~286 (2002)
- Wilcox, R. A., "Cutting edge: Expression of functional CD137 receptor by dendritic cells", J. Immunol, 168, pp.4262~4267 (2002)
- Drenkard, D., "CD137 is expressed on blood vessel walls at sites of inflammation and enhances monocyte migratory activity", FASEB J, 21, pp.456~463 (2007)
- Kim, C. S, "Deficiency for Costimulatory Receptor 4-1BB Protects Against Obesity-Induced Inflammation and Metabolic Disorders", DIABETES, 60(12), pp.3159~3168, AMER DIABETES ASSOC
- 박윤지, "Cutting Edge: 4-1BB Controls Regulatory Activity in Dendritic Cells through Promoting Optimal Expression of Retinal Dehydrogenase", JOURNAL OF IMMUNOLOGY, 189(6), pp.2697~2701, AMER ASSOC IMMUNOLOGISTS
- Kim, J., "Superscript CD25+CD4+Foxp3+ regulatory T cells primed by anti-CD137 mAbs inhibit graft-versus-host disease", Biol. Blood Marrow Transplant, 18, pp.44~54 (2012)
- Saiki, H., "Blockade of the 4-1BB pathway attenuates graft arterial disease in cardiac allografts", Int. Heart J, 49, pp.105~118 (2008)
- 권병석, "CD137-CD137 Ligand Interactions in Inflammation", Immune Network, 9(3), pp.84~89 (2009), 대한면역학회
- Shao, Z., "CD137 ligand, a member of the tumor necrosis factor family, regulates immune responses via reverse signal transduction", J. Leukoc. Biol, 89, pp.21~29 (2011)
- Kim, D. K, "CD137 ligand- mediated reverse signals increase cell viability and cytokine expression in murine myeloid cells: involvement of mTOR", p70S6 kinase and Akt, 2009, pp.39, 2617~2628
- Kang, Y. J, "Cell surface 4-1BBL mediates sequential signaling pathways 'downstream' of TLR and is required for sustained TNF production in macrophages", Nat. Immunol, 8, pp.601~609 (2007)
- 김정대, "Recombinant TAT-CD137 Ligand Cytoplasmic Domain Fusion Protein Induces the Production of IL-6 and TNF-α in Peritoneal Macrophages", Immune Network, 11(4), pp.216~222 (2011), 대한면역학회
- Kim, H. J, "Reverse signaling through the costimulatory ligand CD137L in epithelial cells is essential for natural killer cell-mediated acute tissue inflammation", Proc. Natl. Acad. Sci. USA, 109, pp.E13~E22 (2012)
- Sang Jun Park, "Reverse Signaling through the Co-Stimulatory Ligand, CD137L, as a Critical Mediator of Sterile Inflammation", Molecules and Cells, 33(6), pp.533~537 (2012), 한국분자세포생물학회[DOI]